Pharmaceutical composition for the reducing both hyperlipidemia and platelet-aggregation (PHP)

A process for producing scoparone from a plant selected from the group consisting of Artemisia capillaris Thunb, Citrus aurantium L., and Poncirus trifoliata Raf comprising:

• a. extracting a powder of the plant with 95% ethanol at 50.degree. C. for 12 hrs;
• b. concentrating the resulting ethanol extract under reduced pressure to yield a residue;
• c. dissolving said residue in water to yield an aqueous solution;
• d. extracting said aqueous solution with chloroform and separating chloroform from the aqueous solution;
• e. extracting the aqueous solution of step d, with aceticether;
• f. drying the aceticether with sodium sulfate;
• g. distilling the remaining aceticether to yield a residue;
• h. dissolving the residue of step e in methanol;
• i. concentrating the resulting methanol solution of yield crystal scoparone.